Title | Creator | Relation Is Part Of | ||
---|---|---|---|---|
1 | Good Therapies Gone Bad - What the Neuro-Ophthalmologist Needs to Know | Fiona Costello, MD, FRCP | NANOS Annual Meeting 2023: Neuroimmunology: https://novel.utah.edu/collection/NAM/toc/ | |
2 | Good Therapies Gone Bad - What the Neuro-Ophthalmologist Needs to Know | Fiona Costello, MD, FRCP | NANOS Annual Meeting 2023: Neuroimmunology | |
3 | Idiopathic Intracranial Hypertension: Management Challenges | Susan P. Mollan, FRCOphth | NANOS Annual Meeting 2023: State of the Art - Global Perspectives | |
4 | Optic Nerve Hypoplasia: Controversies in Embryogenesis | Michael Brodsky, MD | NANOS Annual Meeting 2023: Insight Into Neuroanatomy: Learning From Pediatric Neuro-Ophthalmic Disorders | |
5 | A Randomized Controlled, Trial of the GLP-1 Receptor Agonist Exenatide in Idiopathic Intracranial Hypertension | James Mitchell, Major RAMC | NANOS Annual Meeting 2022: Scientific Platform Session II | |
6 | Mitochondrial Genetics - From Genes to Disease Mechanisms | Valerio Carelli, MD, PhD | NANOS Annual Meeting 2022: Mitochondrial Disorders: More Than the Optic Nerve | |
7 | AION Precipitants (PDF) | Anthony Arnold, MD, Clare Fraser, FRANZCO, Howard Pomeranz, MD, PhD, Helen Danesh-Meyer, MD, PhD | NANOS Annual Meeting 2020: Hot Topics | |
8 | OCT and Neurodegeneration of Alzheimer's Disease and Parkinson's Disease (abstract) | Victoria S. Pelak, MD | NANOS Annual Meeting 2017: Hot Topics in OCT | |
9 | A Novel Mechanism for the Central Nervous System Transit of Aquaporin-4 Autoantibody in Neuromyelitis Optica (abstract) | Jeffrey Bennett, Fumitaka Shimizu, Kristin Schaller, Gregory Owens, Anne Cotleur, Debra Kellner, Yukio Takeshita, Birgit Obermeier, Thomas Kryzer, Yasuteru Sano, Takashi Kanda, Vanda Lennon, Richard Ransohoff | NANOS Annual Meeting 2017: Scientific Platform II | |
10 | Side Effects of New Immuno-Modulators (abstract) | Ore-ofe Oluwaseun Adesina, MD | NANOS 2017: Neuro-Ophthalmologic Side Effects of More Recently Used Medications in Treating Cancer, Rheumatologic Disorders, and Multiple Sclerosis |